Evaluation of time-to-recurrence of disease activity in treatment-naive patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study

导出原文传递

翻译打印收藏纠错

作者： Quaranta, Maddalena ^[1] ; Devin, Francois ^[2] ; Quentel, Gabriel ^[3] ; Uzzan, Joel ^[4] ; Fourmaux, Eric ^[5] ; Castelnovo, Laurent ^[6] ; Roquet, Wilfried ^[7] ; Francais-Maury, Catherine ^[8] ; Razavi, Sam ^[9] ; San Nicolas, Nathalie ^[10]

作者单位： Ctr Rabelais, Ophthalmol, Lyon, France ^[1] Clin St Gatien, Ophthalmol, Tours, France ^[2] Ctr Odeon, Ophthalmol, Paris, France ^[3] Clin Mathilde, Ophthalmol, Rouen, France ^[4] Ctr Imagerie & Laser, Ophthalmol, Paris, France ^[5] Retine Gallien, Ophthalmol, Bordeaux, France ^[6] Clin Maison Rouge, Ophthalmol, Strasbourg, France ^[7] Novartis Pharma SAS, Ophthalmol, Rueil Malmaison, France ^[8] Ctr Monticelli Paradis, Ophthalmol, Marseille, France ^[9] Ctr Blatin, Ophthalmol, Clermont Ferrand, France ^[10]

发布时间 2020-08-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Investigative ophthalmology & visual science

2017年58卷8期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluation of time-to-recurrence of disease activity in treatment-naive patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study

Investigative ophthalmology & visual science

相似文献

Investigative ophthalmology & visual science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of time-to-recurrence of disease activity in treatment-naive patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study

Investigative ophthalmology & visual science

相似文献

Investigative ophthalmology & visual science

相关期刊

检索历史清除